-
England edge ahead in third Test after latest Pakistan collapse
-
How hot can the US-Canada trade war get?
-
'Alarm bells ringing': US summer heat shatters record
-
Iran strikes ships, expands no-go zone outside Hormuz strait
-
IAEA board refers Iran to UN Security Council
-
'Gambling with our lives': AI researcher quits Anthropic
-
Rubio pushes extraditions, anti-drug fight in Ecuador
-
Belgium raids illicit cigarette factory in push to stub out growing trade
-
Amboss and Aureo Connect the Lightning Network to Mexico's Banking System
-
Vuelta debutant Brennan claims fifth victory on stage 17
-
Brent oil passes $100 on Mideast flare-up, stoking inflation fears
-
US had warmest summer on record: climate agency
-
Israeli settlement winemaker defiant after UK-led trade sanctions
-
Meta tests fact-check replacement in Latin America
-
Josh Kerr: I pick my races and never get 'greedy'
-
Soviet brutality, ideology backdrop of controversial Venice film
-
Carrick confident Man Utd can go far in 'magical' Champions League
-
McIlroy predicts player exodus after LIV files for bankruptcy protection
-
France far right expels policeman member over racist remarks
-
Global Multi-Asset Broker FP Markets Secures UAE CMA Category 5 Licence
-
Pakistan collapse to 133 all out against England in 3rd Test
-
Brent oil passes $100 on Mideast flare-up, stoking inflation worries
-
Heat forces French champagne makers to stiffen their drink
-
'Nothing left': thousands in Yemen flee deadly Houthi clashes
-
Iran war drives oil prices to $100 per barrel as Tehran strikes ships
-
Spain endured hottest summer on record: weather agency
-
Pakistan collapse to 100-7 against England in 3rd Test
-
'A celebration': Amsterdam museum unveils Kusama show weeks after death
-
Workers, migrants focus of documentaries by Oscar winners at Venice
-
IC Markets Australia Wins People's Choice Forex Broker Innovation Award at the 2026 Finder Innovation Awards
-
Nepal seeks survivors two weeks after deadly floods
-
Brent oil tops $100 on Mideast flare-up, fanning inflation fears
-
Bangladesh measles crisis kills more than 1,000 children
-
EU wants to edge out China in public contracts
-
Pakistan collapse to 26-4 against England in 3rd Test
-
Google unveils 13 bn euro AI expansion in Finland
-
EU helps cities tighten screws on Airbnb, holiday rentals
-
Singapore's hefty ministerial pay hikes draw mixed feelings
-
Courtois to put Belgium career on hold
-
Cyberattack ruled out in UK air traffic glitch as more flights axed
-
RavenDB Launches Quill to Bring Production AI Agents to Enterprise SQL Systems, No Migration Required
-
Ekiden Launches Canton Network’s First Order Book-Based Derivatives Exchange
-
Affleck family affair at Venice for Casey's latest film 'Company'
-
Germany's Merz accuses AfD of promoting 'ethnic cleansing'
-
Yemen rebels report fresh Saudi strikes as conflict deepens
-
Japanese director Kore-eda's manga film charms critics in Venice
-
'They're playing with our lives': AI researcher quits Anthropic
-
As African space race heats up, Senegal pursues homemade satellites
-
Series finale of 'Babylon Berlin' offers dark mirror for today's Germany
-
UK's little-known Bayeux Tapestry replica steps into spotlight
'Blessed': US woman sees second chance in life after pig kidney transplant
Towana Looney donated a kidney to her mother in 1999 only for the remaining one to fail several years later due to pregnancy complications.
Now, the 53-year-old from Alabama has become the latest recipient of a gene-edited pig kidney -- and is currently the only living person in the world with an animal organ transplant, New York's NYU Langone hospital announced Tuesday.
"I'm overjoyed, I'm blessed to have received this gift, this second chance at life," Looney said during a press conference, held three weeks after the procedure.
Xenotransplantation, the process of transplanting organs from one species to another, has long been a tantalizing yet elusive scientific goal. Early experiments on primates faltered. But recent advances in gene editing and immune system management have brought the dream closer to reality.
Pigs have emerged as the ideal donors: they grow quickly, produce large litters and are already part of the human food supply.
Advocates hope this approach can help address the severe organ shortage in the United States, where more than 100,000 people are waiting for transplants, including over 90,000 in need of kidneys.
- A last chance -
Looney had been living with dialysis since December 2016 -- eight grueling years. High blood pressure caused by preeclampsia had taken its toll, leaving her with chronic kidney disease.
Despite receiving priority on transplant waiting lists as a living donor, her search for a compatible kidney was a frustrating dead end. Her unusually high levels of harmful antibodies made rejection almost inevitable, and as her body lost viable blood vessels to support dialysis, her health declined.
Out of options, Looney applied to join a clinical trial for pig kidney transplants, and finally underwent the seven-hour surgery on November 25.
Asked how she felt afterward, Looney's joy was infectious. "I'm full of energy, I've got an appetite... and of course, I can go to the bathroom. I haven't been going in eight years!" she laughed, adding that she was looking forward to celebrating at Disney World.
Jayme Locke, a surgeon on the transplant team, described the results with awe. "The kidney functioned essentially exactly like a kidney from a living donor," she said, adding that Looney's husband saw a rosiness in her cheeks for the first time in years.
"That is the miracle of transplantation."
- Cautious optimism -
Looney's surgery is the third time a gene-edited pig kidney has been transplanted into a human who is not brain dead.
Rick Slayman, the first recipient, died in May, two months after his procedure at Massachusetts General Hospital. The second, Lisa Pisano, initially showed signs of recovery following her surgery at NYU Langone, but the organ had to be removed after 47 days, and she passed away in July.
Looney, however, was not terminally ill before the transplant, noted Robert Montgomery, who led the surgery. He said each case offers valuable lessons, helping teams refine their techniques.
The kidney was provided by biotech company Revivicor, which breeds pigs with genetically modified kidneys less likely to be rejected by patients' immune systems.
It features 10 genetic edits to enhance compatibility with the human body -- an advance over earlier efforts that used kidneys with a single gene edit and included the pig's thymus gland to help train the host's immune system and prevent rejection.
Both methods are expected to undergo clinical trials "probably by this time next year, or even sooner," Montgomery added.
A pioneer in the field, Montgomery performed the first gene-edited pig organ transplant into a neurologically deceased patient in 2021. Looney's surgery marks his seventh human xenotransplantation.
Looney was discharged December 6 to a nearby New York City apartment. Though her high antibody levels remain a concern, doctors are monitoring her closely using wearable technology and are trying a novel drug regimen to prevent rejection.
Periodic hospital visits may still be required, but the team remains optimistic she can return home in three months.
K.Sutter--VB